Targeting the shedding of transmembrane PD-L1 to enhance therapeutic efficacy of immune checkpoint inhibitors
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2110191
- Recipient
-
Icahn School Of Medicine At Mount Sinai UEI C8H9CNG1VBD9
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $169,499
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Originally
- Place of performance
- New York, NY 10029, USA
Award details come from USAspending.gov.
About this award
The Icahn School of Medicine at Mount Sinai will target the shedding of transmembrane PD-L1 to enhance therapeutic efficacy of immune checkpoint inhibitors under a $169,499 Project Grant from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative and impactful investigations. Specifically, the Icahn School of Medicine will investigate medical solutions for the battlefield by exploring how modulating PD-L1 shedding can improve immune checkpoint inhibitor therapy outcomes for service members and the general public. The two-year award period will allow the grantee to conduct the proposed research from June 2021 through May 2023 at their New York location.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $169,499 |
Quick answers
Who received award W81XWH2110191?
W81XWH2110191 was awarded to Icahn School Of Medicine At Mount Sinai by Medical Command (Department of the Army) on June 1, 2021.
How much is award W81XWH2110191 worth?
$169,499 has been obligated on W81XWH2110191.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award